Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Omeros

November 2025

Omeros Market Share Analysis for November 2025

omeros is breaking the mold in the pharmaceutical industry through novel discovery, strategic translational research, and vigorous clinical programs.
Year Founded1994
Employees51 - 200
Annual Revenue$75M - $100M
omeros.com
Omeros
Omeros (including company regionals)
  • omeros.com
    omeros.com
See more website traffic and engagement information

Omeros Revenue up to November 2025 is 75M - 100M

revenue generated by Omeros top domains

Omeros top domains revenue over 3 years

Revenue for Omeros top domains


Total visits to Omeros's top domains

Understand Omeros market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Omeros's top domains

Analyze Omeros engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Omeros's top domains

See how Omeros keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Omeros

These are the website technologies, by industry, used by Omeros top domains

Widget (6)

Twemoji

Twemoji

Audio Video Media (3)

YouTube

YouTube

Email Services (3)

Rackspace MailGun

Rackspace MailGun

Advertising (2)

DoubleClick

DoubleClick

More Technologies

10

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Omeros

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovo Nordisk A/S partners with Omeros Corporation.Danish pharma giant Novo Nordisk has inked a definitive deal with Omeros Corporation to acquire its late-stage-ready rare disease asset, zaltenibart.
NewsOmeros Corporation is developing OMS527 for the treatment of CUD.Omeros is developing OMS527 for the treatment of CUD at NIDA's direct request.
NewsOmeros Corporation attends event 2025 Tandem Meetings.Omeros Corporation announces availability on its website of materials accompanying narsoplimab presentations at the 2025 Tandem Meetings.

See all Omeros signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.